Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07165860 · ClinicalTrials.gov registry record · NA
Clinical Trial to Reduce Perinatal Intimate Partner Violence
A NA study of Domestic Violence and Perinatal Problems, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 326
- Enrollment target
- 3
- Study locations
NCT07165860: Recruiting NA study of Domestic Violence and Perinatal Problems, sponsored by University of Pittsburgh.
NCT07165860 is a NA study of Domestic Violence and Perinatal Problems that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 326 participants, below the 441-participant average among 12 other Domestic Violence trials with a reported enrollment target (26% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07165860, a NA study of Domestic Violence and Perinatal Problems, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 326 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a two-armed, fully powered hybrid type 1 trial to test the effectiveness of a doula intervention compared with an active control in reducing intimate partner violence (IPV) among perinatal IPV survivors
Primary Outcome
15 item Composite Abuse Scale Short form, scale is 0 to 5 and 15 items are added for a summary score, higher number means more IPV
Conditions Studied
Interventions
- BEHAVIORAL Doulas
- BEHAVIORAL Thrive
Study Locations (3)
Pennsylvania
- Magee Women's Hospital - Pittsburgh
- The Midwife Center - Pittsburgh
- Family Medicine Department - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 326 participants |
| Start Date | 2025-11-01 |
| Est. Completion | 2029-10 |
| Phase | NA |
What NCT07165860 shows while recruiting
NCT07165860 is an interventional study that assigns participants to a tested intervention. The registered 326 participants enrollment target is mid-sized for trials with a published cap, below the 441-participant average among 12 other Domestic Violence trials with a reported enrollment target (26% lower).
The record links to 2 conditions, with Domestic Violence appearing as the primary indexed condition, and to 2 interventions - of which Doulas is the first listed.
NCT07165860 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07165860 about?
NCT07165860 is a clinical study titled "Clinical Trial to Reduce Perinatal Intimate Partner Violence". This is a two-armed, fully powered hybrid type 1 trial to test the effectiveness of a doula intervention compared with an active control in reducing intimate partner violence (IPV) among perinatal IPV survivors
What is the current status of trial NCT07165860?
This trial is currently recruiting. It is a NA study. The enrollment target is 326 participants. The study started on 2025-11-01. Estimated completion is 2029-10.
What conditions does trial NCT07165860 study?
This clinical trial studies the following conditions: Domestic Violence, Perinatal Problems.
What interventions are being tested in trial NCT07165860?
The interventions under investigation include: Doulas (BEHAVIORAL), Thrive (BEHAVIORAL).
Who is sponsoring clinical trial NCT07165860?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07165860 being conducted?
This trial has 3 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Domestic Violence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07165860's enrollment target sits among peer trials
326 5th of 12 higher than 8 of 12 other Domestic Violence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Domestic Violence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Occupational Therapy for Adults Who Have Experienced Intimate Partner Violence (IPV)
RECRUITING · NA
-
Single Session Intervention to Promote Hope
RECRUITING · NA
-
Safety and Effectiveness of Computer Screening for Intimate Partner Violence
COMPLETED · NA
-
Using Implementation Science to Increase Pre-Exposure Prophylaxis Uptake Among African American Women
COMPLETED · NA
-
Microfinance and Health Intervention Trial for Youth in Dar es Salaam, Tanzania
COMPLETED · NA
-
An Integrated Substance Abuse-Domestic Violence (SADV) Treatment Outcome Study
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06410144 · 326 participants · NA
Chronic Kidney Disease-Education (CKD-EDU)
- NCT06586619 · 326 participants · NA
A Remotely Delivered Tai Chi/Qigong Intervention for Older People Living With HIV
- NCT07040566 · 326 participants · Phase 2
A Trial of Varenicline for E-cigarette Cessation
- NCT04486378 · 327 participants · Phase 2
A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI